Avelumab (Anti-Pd-L1) In Patients With Platinum-Treated Advanced Nsclc: 2.5-Year Follow-Up From The Javelin Solid Tumor Trial.Arun Rajan,James L. Gulley,David R. Spigel,Nicholas Iannotti,Jason Claud Chandler,Deborah J.L. Wong,Joseph W. Leach,William Jeffery Edenfield,Ding Wang,Charles H. Redfern,Hans Juergen Grote,Anja von Heydebreck, Mary M. Ruisi, Neru Munshi,Karen KellyJOURNAL OF CLINICAL ONCOLOGY（2018）引用 7|浏览70暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
